Ubs Group Ag Scholar Rock Holding Corp Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Ubs Group Ag holds 177,265 shares of SRRK stock, worth $5.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

177,265

Previous 84,704 109.28%

Holding current value

$5.44 Million

Previous $3.66 Million 55.71%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$32.15 - $45.55 $2.98 Million - $4.22 Million	92,561 Added 109.28%	177,265 $5.7 Million
Q4 2024 Feb 14, 2025	SELL	$7.07 - $45.73 $673,049 - $4.35 Million	-95,198 Reduced 52.92%	84,704 $3.66 Million
Q3 2024 Nov 14, 2024	SELL	$7.63 - $9.71 $1.87 Million - $2.38 Million	-245,410 Reduced 57.7%	179,902 $1.44 Million
Q2 2024 Aug 13, 2024	SELL	$7.84 - $16.79 $56,032 - $119,998	-7,147 Reduced 1.65%	425,312 $3.54 Million
Q1 2024 May 13, 2024	BUY	$13.2 - $17.76 $5.71 Million - $7.68 Million	432,216 Added 177866.67%	432,459 $7.68 Million
Q4 2023 Feb 09, 2024	SELL	$6.52 - $20.32 $167,283 - $521,350	-25,657 Reduced 99.06%	243 $4,000
Q3 2023 Nov 09, 2023	BUY	$6.02 - $7.76 $28,751 - $37,061	4,776 Added 22.61%	25,900 $183,000
Q2 2023 Aug 11, 2023	BUY	$5.79 - $9.11 $97,248 - $153,011	16,796 Added 388.08%	21,124 $159,000
Q1 2023 May 12, 2023	BUY	$7.36 - $12.72 $23,448 - $40,525	3,186 Added 278.98%	4,328 $34,000
Q4 2022 Feb 08, 2023	BUY	$7.02 - $9.76 $2,878 - $4,001	410 Added 56.01%	1,142 $10,000
Q3 2022 Nov 10, 2022	SELL	$5.33 - $11.3 $1,599 - $3,390	-300 Reduced 29.07%	732 $5,000
Q2 2022 Aug 10, 2022	BUY	$4.66 - $13.96 $4,809 - $14,406	1,032 New	1,032 $6,000
Q3 2021 Nov 15, 2021	SELL	$27.38 - $42.21 $19,385 - $29,884	-708 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$26.34 - $46.62 $18,648 - $33,006	708 New	708 $20,000
Q3 2020 Nov 12, 2020	SELL	$10.54 - $18.47 $60,973 - $106,848	-5,785 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$10.37 - $20.64 $13,325 - $26,522	-1,285 Reduced 18.18%	5,785 $105,000
Q1 2020 May 01, 2020	SELL	$9.63 - $17.14 $121,010 - $215,381	-12,566 Reduced 63.99%	7,070 $86,000
Q4 2019 Feb 14, 2020	BUY	$7.2 - $13.2 $32,724 - $59,994	4,545 Added 30.12%	19,636 $259,000
Q3 2019 Nov 14, 2019	BUY	$8.95 - $15.72 $104,813 - $184,096	11,711 Added 346.48%	15,091 $135,000
Q2 2019 Aug 14, 2019	BUY	$14.61 - $22.45 $49,381 - $75,881	3,380 New	3,380 $54,000
Q1 2019 May 14, 2019	SELL	$14.24 - $22.28 $32,723 - $51,199	-2,298 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$17.86 - $28.77 $14,841 - $23,907	831 Added 56.65%	2,298 $53,000
Q3 2018 Nov 14, 2018	SELL	$13.39 - $26.25 $20,674 - $40,530	-1,544 Reduced 51.28%	1,467 $38,000
Q2 2018 Aug 14, 2018	BUY	$15.0 - $25.6 $45,165 - $77,081	3,011 New	3,011 $47,000

Others Institutions Holding SRRK

# of Institutions

247

Shares Held

89.9M

Call Options Held

706K

Put Options Held

456K

View Full List

About Scholar Rock Holding Corp

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $1.58B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

More about SRRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account